Effects of low- or high-dose hormone therapy on fasting and post-methionine homocysteine levels in postmenopausal women

References

• Mudd S H, Levy H L. Disorders in transsulfuration. Metabolic Bases of Inherited Disease5th edn., J B Stanbury, J B Wyngaaden, D S Fredrickson, J L Goldstein, M S Brown. McGraw-Hill, New York 1995; 1279–1327
   Google Scholar
• Moustapha A, Robinson K. Homocysteine: an emerging age-related cardiovascular risk factor. Geriatrics 1995; 54: 49–63
   Google Scholar
• Ueland P M, Refsum H, Stabler S P, Malinow M R, Andersson A, Allen R H. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764–1779
   PubMed Web of Science ®Google Scholar
• Aguilar B, Rojas J C, Collados M T. Metabolism of homocysteine and its relationship with cardiovascular disease. J Thromb Thrombolysis 2004; 18: 75–87
   PubMed Web of Science ®Google Scholar
• Graham I M, Daly L E, Refsum H M, et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997; 277: 1775–1781
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Martinelli I, Mannucci P M. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 335: 974–976
   PubMed Web of Science ®Google Scholar
• Selhub J, Jacques P F, Wilson P WF, Rush D, Rosemberg I H. Vitamin status and intake as a primary determinant of homocysteine in the elderly. JAMA 1993; 270: 2693–2698
   PubMed Web of Science ®Google Scholar
• Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994; 236: 633–641
   PubMed Web of Science ®Google Scholar
• Jacobsen D W, Gatautis V J, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem 1994; 40: 873–881
   PubMed Web of Science ®Google Scholar
• Wouters M G, Moorrees M T, van der Mooren M J, et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995; 25: 801–815
   PubMed Web of Science ®Google Scholar
• Hak A E, Polderman K H, Westendorp I C, et al. Increased plasma homocysteine after menopause. Atherosclerosis 2000; 149: 163–168
   PubMed Web of Science ®Google Scholar
• van der Mooren M J, Wouters M G, Blom H J, Schellekens L A, Eskes T K, Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest 1994; 24: 733–736
   PubMed Web of Science ®Google Scholar
• Barnabei V M, Phillips T M, Hsia J. Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Womens Health Gend Based Med 1999; 8: 1167–1172
   PubMedGoogle Scholar
• Van Baal W M, Smolders R G, van der Mooren M J, Teerlink T, Kenemans P. Hormone replacement therapy and plasma homocysteine levels. Obstet Gynecol 1999; 94: 485–491
   PubMed Web of Science ®Google Scholar
• Walsh B W, Paul S, Wild R A, Tracy R P, Cox D A, Anderson P W. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 2000; 85: 214–218
   PubMed Web of Science ®Google Scholar
• Mijatovic V, Kenemans P, Netelenbos C, et al. Postmenopausal oral 17β-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels. Fertil Steril 1998; 69: 876–882
   PubMed Web of Science ®Google Scholar
• Mijatovic V, Kenemans P, Jakobs C, van Baal W M, Peters-Muller E R, van der Mooren M J. A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol 1998; 91: 432–446
   PubMed Web of Science ®Google Scholar
• Chiantera V, Sarti C D, Fornaro F, et al. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels. Menopause 2003; 10: 286–291
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Malmusi S, Zanni A L, Alessandrini C, Caretto S, Volpe A. Comparison of the effect of oral and transdermal hormone therapy on fasting and postmethionine homocysteine levels. Fertil Steril 2004; 81: 99–103
   PubMed Web of Science ®Google Scholar
• Berger P B, Herrmann R R, Dumesic D A. The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women. Mayo Clin Proc 2000; 75: 18–23
   PubMed Web of Science ®Google Scholar
• Ventura P, Cagnacci A, Malmusi S, et al. Continuous combined hormone replacement therapy with oral 17 beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women. Menopause 2001; 8: 252–258
   PubMed Web of Science ®Google Scholar
• Smolders R G, de Meer K, Kenemans P, Teerlink T, Jakobs C, van der Mooren M J. Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2004; 117: 55–59
   PubMed Web of Science ®Google Scholar
• Tutuncu L, Ergur A R, Mungen E, Gun I, Ertekin A, Yergok Y Z. The effect of hormone therapy on plasma homocysteine levels: a randomized clinical trial. Menopause 2005; 12: 216–222
   PubMed Web of Science ®Google Scholar
• Stampfer M J, Willett W C, Colditz G A, Rosner B, Speizer F E, Hennekens C H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985; 313: 1044–1049
   PubMed Web of Science ®Google Scholar
• Grady D, Rubin S M, Petitti D B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–1037
   PubMed Web of Science ®Google Scholar
• Grodstein F, Manson J E, Colditz G A, Willett W C, Speizer F E, Stampfer M J. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000; 133: 933–941
   PubMed Web of Science ®Google Scholar
• Grady D, Herrington D, Bittner V, et al. HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 49–57
   PubMed Web of Science ®Google Scholar
• Rossouw J E, Anderson G L, Prentice R L, et al. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Cornwell P E, Morgan S L, Vaughn W H. Modification of a high performance liquid chromatographic method for assay of homocysteine in human plasma. J Chromatogr B 1993; 617: 136–139
   Google Scholar
• Dankner R, Chetrit A, Lubin F, Sela B A. Life-style habits and homocysteine levels in an elderly population. Aging Clin Exp Res 2004; 16: 437–442
   PubMed Web of Science ®Google Scholar
• Evio S, Tiitinen A, Turpeinen U, Ylikorkala O. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels. Fertil Steril 2000; 74: 1080–1083
   PubMed Web of Science ®Google Scholar
• Melse-Boonstra A, Holm P I, Ueland P M, Olthof M, Clarke R, Verhoef P. Betaine concentration as a determinant of fasting total homocysteine concentrations and the effect of folic acid supplementation on betaine concentrations. Am J Clin Nutr 2005; 81: 1378–1382
   PubMed Web of Science ®Google Scholar
• Jencks D A, Mathews R G. Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium. J Biol Chem 1987; 262: 2485–2493
   PubMed Web of Science ®Google Scholar
• Finkelstein J D, Kyle W E, Martin J L, Pick A M. Activation of cystathionine synthase by adenosylmethionine and adenosylethionine. Biochem Biophys Res Commun 1975; 66: 81–87
   PubMed Web of Science ®Google Scholar
• Finkelstein J D. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 1998; 157(Suppl 2)S40–S44
   PubMed Web of Science ®Google Scholar
• Lee G R, Herbert V. Nutritional factors in the production and function of erythrocytes. Wintrobes's Clinical Hematology10th edn., G R Lee, J Foerster, J Lukens, F Paraskevas, J P Greer, G M Rodgers. Williams & Wilkins, Baltimore 1999; 228–266
   Google Scholar
• Carmel R. R binder deficiency. A clinical benign cause of cobalamin pseudodeficiency. JAMA 1983; 250: 1886–1890
   PubMed Web of Science ®Google Scholar
• Hakami N, Neimann P, Canellos G P, Lazerson J. Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings. N Engl J Med 1971; 285: 1163–1170
   PubMed Web of Science ®Google Scholar
• Gardyn J, Mittelman M, Zlotnik J, Sela B A, Cohen A M. Oral contraceptives can cause falsely low vitamin B (12) levels. Acta Haematol 2000; 104: 22–24
   PubMed Web of Science ®Google Scholar
• Shojania A M, Wylie B. The effect of oral contraceptives agents on vitamin B12 metabolism. Am J Obstet Gynecol 1979; 135: 129–134
   PubMed Web of Science ®Google Scholar